PharmaAbbVie Partners With Iambic to Accelerate AI-Driven Drug Discovery
AbbVie will use Iambic's AI platform and Enchant v3 to accelerate small-molecule drug discovery across immunology, neuroscience and oncology.
Pharma · Company
AbbVie
Covered since Most recent
AbbVie has partnered with Iambic to enhance its drug discovery efforts by utilizing Iambic's AI platform and Enchant v3. This collaboration aims to expedite the development of small-molecule drugs in the fields of immunology, neuroscience, and oncology.
0Stories
+0 in the last 30 days
0Deployments tracked
1 announced
multi-yearcollaboration type
Latest tracker entry
Deployments
In the tracker →- Enchant v3
announcedmulti-year Iambic
Stories
1 storyPharma
